logo
I covered the L.A. fires in the Palisades. So I had my blood tested for lead

I covered the L.A. fires in the Palisades. So I had my blood tested for lead

Yahoo02-07-2025
I watched my blood snake through the tube stuck into my arm as I sat under a canopy erected by the Los Angeles County Department of Public Health at an Altadena church.
Four months prior — almost to the hour — I stepped out of my car in Pacific Palisades to wailing sirens, raining ash and fleeing people.
Now, like hundreds of others, I desperately wanted to know: Had lead once locked away in the homes of the Palisades and Altadena seeped into my bloodstream? And, if so, how much now sat in the vial in the hands of Jessica Segura, a nurse with the Department of Public Health?
Tania Rysinski took my chair after me. She had evacuated from Pasadena and, after a trying remediation process, had moved back home with her husband and 3-year-old daughter. I asked what brought her to the Eaton fire resource fair.
'I also worry,' she told me. 'My daughter is the one that we worry about the most.'
Despite hours of reading about and discussing remediation and health hazards with friends and family, Rysinski found little certainty that her family was safe. I shared her apprehension.
Alongside other health and environment reporters at The Times, I've read thick scientific studies, reviewed reams of data and interviewed dozens of experts to understand what dangerous compounds, transported by wind and smoke, had laced our water systems, settled into homes and embedded themselves in the soil and our bodies.
Even so, our reporting left me feeling mostly frustrated with my brain. Several times, after I interviewed residents in the burn areas, they would say: You've covered this in detail. Would you feel comfortable moving back here with kids?
I didn't know.
A 20-foot-tall flame staring at you through the windshield is a very tangible risk. The lead lurking in the air and soil is a different story. It is invisible and damages our bodies in complex ways. And that damage happens quietly.
Segura, the nurse, removed the tube from my arm and pressed a cotton ball to the needle prick. The results would not be a simple positive or negative, she explained. Instead, it would list the concentration in micrograms of lead per deciliter of blood. Anything over 3.5 mcg/dL requires follow-up care, according to the Centers for Disease Control and Prevention.
I could expect results within two weeks, Segura said. I asked Rysinski what her plan was if her levels were high.
'I have no idea,' she said.
Neither did I.
I, admittedly, took little precaution to protect myself from the wildfire smoke during the three days I spent in Pacific Palisades.
My brain focused on more immediate concerns: dodging downed electrical wires, plotting escape routes, jump=starting folks' cars and watching in horror as buildings erupted into flames in front of me.
Rysinski had felt the same in Pasadena. 'We were all on survival mode,' she said.
After retreating to my car, which reeked of smoke, for a brief break the morning after the fires erupted, I got a message from my editor. Like concerned friends and family who had been messaging me from the East Coast — and strangers who'd seen my reports on Instagram — the editor wanted to know what the smoke might be doing to our lungs. And were people worried?
I threw my body weight against the car door, barely managing to out-muscle the wind, and stumbled through gale-force gusts to talk to folks. At a haphazardly parked SUV, Amber Vanderbilt rolled down the window.
'I know this isn't on the top of most people's minds,' I said, 'but I'm curious how you or the people you know have been dealing with the air quality. Has that been a concern for you?'
'No,' she said with a chuckle. 'I see that it's on the news too, which is really funny.' In fact, the discourse had frustrated her enough that she recalled yelling at the TV newscast, 'No one cares! Show me where the fire perimeter is! Tell me where the wind is going!'
I chuckled with her. I too did not care.
Then, I started looking at the data.
On Jan. 8, an air quality sensor in Chinatown had read fine particulate matter at a concentration over 13 times the federal daily limit — the number that had prompted my team to elicit my interview with Vanderbilt.
Amid the scattered, ad hoc testing efforts that followed, one emerged as a leader: the LA Fire HEALTH Study, or the Los Angeles Fire Human Exposure and Long-Term Health Study. Scientists from eight research institutions had banded together with some private funding to, ambitiously, study the health effects of the fires over the course of a decade.
In May, I attended one of their events — supposedly a symposium, definitely a cocktail party and perhaps a fundraiser — at a home in Brentwood.
A Times photographer and I, slightly underdressed, scuttled past the valet and into the backyard. Guests began migrating to the white lawn chairs set up on the tennis court to hear the scientists speak.
The jaunty atmosphere turned tense as Palisadians struggled to make sense of the environmental crisis unfolding in front of them.
'My daughter is a surfer, Pali High student. She's only 17 years old,' one attendee said when the topic of beaches came up. 'Our family is having a really, really hard time telling what the actual truth is.'
Dr. David Eisenman, a UCLA public health professor and an avid surfer, had hit the waves that morning after carefully reviewing the nonprofit Heal the Bay's latest test results that showed no significant levels of contaminants in the water.
But the attendee pushed back.
'I know a mom who spent $6,000 of her own money to have the beach tested and she found ridiculously high levels of arsenic,' she said. 'This is where children are playing. This is insane. So, we don't know who to trust. We don't know what to do.'
The researchers sympathized with her frustration.
For almost every combination of contaminant and domain, scientists have rigorously studied the exposure risk and health impact, and, based on that, the federal and state governments have set screening levels: Any more of a particular contaminant requires additional action.
California's level for lead in residential soil is 80 milligrams per kilogram. That's the amount that, in the worst case, can raise the blood lead level of a child who routinely plays in the soil by 1 mcg/dL. A blood lead level increase in children of 5 mcg/dL corresponds to a loss of roughly 1 to 3 IQ points.
But the problem quickly gets more complicated than that.
Take the state's screening level for arsenic, for example, based on a 1-in-a-million chance of developing cancer over a lifetime of exposure. The level is 0.032 milligram per kilogram of soil. But arsenic naturally occurs in soil, typically 2 to 11 milligrams per kilogram.
When I asked the state Department of Toxic Substances Control about this, it had a shockingly morbid answer. Arsenic occurring naturally at potentially cancer-causing levels, it said, is simply 'a part of living on Earth.'
It's not hard to see why talk of contaminants leaves people frustrated and confused. That includes me, whose full-time job is to figure this stuff out.
Yet one report from the LA Fire HEALTH Study struck me as surprisingly lucid. I couldn't get it out of my head.
Dr. Kari Nadeau, a researcher with the study and professor at the Harvard T.H. Chan School of Public Health, has been collecting firefighters' blood for years. After the L.A. County wildfires, she did the same.
The results: The firefighters who battled L.A. County's urban fires had lead levels in their blood five times of those who had battled forest fires in Yosemite.
Technically, no level of lead in the blood is safe, but we all live with it in our blood. The average American's blood lead level sits around 0.8 mcg/dL.
Elevated levels in kids — above 3.5 mcg/dL, according to the CDC — can cause significant brain and nerve damage leading to slowed development and behavioral issues. Adults are less sensitive to lead, but under much higher concentrations — beyond 40 mcg/dL — the metal, which the body mistakes for calcium, can damage many organs.
When I read my colleague's coverage of Nadeau's findings in March, a thought flickered from the back of my mind: What was in my blood?
As I waited for my blood test results via snail mail, I became increasingly interested not only in what the environmental health risks of the fires are, but also how our brains process them.
Spending so much time in the data had changed me. One weekend I sat next to a campfire, and as I admired the dancing flames, I also imagined the benzene and polycyclic aromatic hydrocarbons the fire was stripping from the wood and whispering into the air for me to inhale. In my head, I recited the federal and state screening levels for airborne chemicals, like a high school student studying for a chemistry exam.
So, I called professor Wändi Bruine de Bruin, director of the Schaeffer Institute's Behavioral Science and Policy Initiative at USC and an expert on the psychology of risk assessment.
'Any situation with environmental risk can be hard to comprehend … but with the fires, it is much more complex,' she said. Stacking multiple risks with limited information while likely dealing with a lost home and uncertain future — 'it's a lot.'
To escape the helpless quest to find solace and certainty in the numbers, Bruine de Bruin recommended focusing on the most relevant data to you from trusted experts or your own testing, then shifting your focus to simple, accessible actions to limit future exposure.
Dr. Michael Crane, a leading health expert in the response to 9/11 and the following environmental disaster, agreed with Bruine de Bruin.
'It's funny, if you make a decision about it, you usually get some peace on that point,' Crane said. 'I would urge people to manage the controllable risks — the ones that are right there, in their fingers.'
As the initial shock of the terrorist attacks morphed into trauma, the very real long-term cancer risk posed by the smoke and debris began to sink in among New York's medical community. Crane recalled when an expert from the National Cancer Institute came down to talk with doctors.
'Fantastic young guy, and I mean, we basically surrounded him,' he said.
The doctors unloaded all their burning cancer questions until one finally yelled, 'Well, what do you think we should do?"
'Get them to stop smoking,' the expert bluntly replied.
Suffice to say, it did not soothe the doctors' concerns.
'He was lucky to get out of that room alive at that point,' Crane said.
Yet that one sentence, Crane believes, is a large part of why the cancer rates never reached the sky-high levels many of those doctors feared.
Since we don't have silver-bullet medical techniques to reverse the effects of exposure to all harmful contaminants, it's prudent we try to prevent another exposure and lead healthy lives. For doctors, it means staying vigilant: aware of their patients' risks and ready to act should those risks become a reality.
Crane chuckled as he recalled the seeming absurdity of the expert's cancer comment; then he turned sincere. "We're very grateful for that guy,' he said.
Ten days after my blood test, a letter from the Department of Public Health arrived. I quickly opened it.
The lead level in my blood: less than 1 mcg/dL.
Rysinski texted me a few days later to share that her results were the same.
In fact, of the 1,350 individuals concerned about their exposures from the wildfires who had partaken in the county's lead blood testing program as of May 31, only seven had levels greater than 3.5 mcg/dL. All were adults older than 40; all lead levels were under 10 mcg/dL.
Dr. Nichole Quick, chief medical advisor for the Department of Public Health, wants people to remain cautious about contamination but is pleased by the initial results of the county's lead testing program.
'The results are reassuring,' Quick told me, looking at numbers from the beginning of May.
Reassuring not that contamination isn't present — it is — but that many of us are taking the simple, manageable steps to lower our risk.
To face the often scary and seemingly insurmountable challenge of making it through our scarred landscape, we must do the little things. Wash our hands, clean the floors and keep the cigarettes away from our lips.
This story originally appeared in Los Angeles Times.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

OpenAI Finally Launched GPT-5. Here's Everything You Need to Know
OpenAI Finally Launched GPT-5. Here's Everything You Need to Know

WIRED

timean hour ago

  • WIRED

OpenAI Finally Launched GPT-5. Here's Everything You Need to Know

OpenAI's blog post claims that GPT-5 beats its previous models on several coding benchmarks, including SWE-Bench Verified (scoring 74.9 percent), SWE-Lancer (GPT-5-thinking scored 55 percent), and Aider Polyglot (scored 88 percent), which test the model's ability to fix bugs, complete freelance-style coding tasks, and work across multiple programming languages. During the press briefing on Wednesday, OpenAI post-training lead Yann Dubois prompted GPT-5 to 'create a beautiful, highly interactive web app for my partner, an English speaker, to learn French.' He tasked the AI to include features like daily progress, a variety of activities like flashcards and quizzes, and noted that he wanted the app wrapped up in a 'highly engaging theme.' After a minute or so, the AI-generated app popped up. While it was just one on-rails demo, the result was a sleek site that delivered exactly what Dubois asked for. 'It's a great coding collaborator, and also excels at agentic tasks,' Michelle Pokrass, a post-training lead, says. 'It executes long chains and tool calls effectively [which means it better understands when and how to use functions like web browsers or external APIs], follows detailed instructions, and provides upfront explanations of its actions." OpenAI also says in its blog post that GPT-5 is 'our best model yet for health-related questions.' In three OpenAI health-related LLM benchmarks—HealthBench, HealthBench Hard, and HealthBench Consensus—the system card (a document that describes the product's technical capabilities and other research findings) states that GPT-5-thinking outperforms previous models 'by a substantial margin.' The thinking version of GPT-5 scored 25.5 percent on HealthBench Hard, up from o3's 31.6 percent score. These scores are validated by two or more physicians, according to the system card. The model also allegedly hallucinates less, according to Pokrass, a common issue for AI where it provides false information. OpenAI's safety research lead Alex Beutel adds that they've "significantly decreased the rates of deception in GPT-5.' 'We've taken steps to reduce GPT-5-thinking's propensity to deceive, cheat, or hack problems, though our mitigations are not perfect and more research is needed,' the system card says. 'In particular, we've trained the model to fail gracefully when posed with tasks that it cannot solve.' The company's system card says that after testing GPT-5 models without access to web browsing, researchers found its hallucination rate (which they defined as 'percentage of factual claims that contain minor or major errors') 26 percent less common than the GPT-4o model. GPT-5-thinking has a 65 percent reduced hallucination rate compared to o3. For prompts that could be dual-use (potentially harmful or benign), Beutel says GPT-5 uses 'safe completions,' which prompts the model to 'give as helpful an answer as possible, but within the constraints of remaining safe.' OpenAI did over 5,000 hours of red teaming, according to Beutel, and testing with external organizations to make sure the system was robust. OpenAI says it now boasts nearly 700 million weekly active users of ChatGPT, 5 million paying business users, and 4 million developers utilizing the API. 'The vibes of this model are really good, and I think that people are really going to feel that,' head of ChatGPT Nick Turley says. 'Especially average people who haven't been spending their time thinking about models.'

Invasive mosquito located at Alameda County Fairgrounds in Pleasanton
Invasive mosquito located at Alameda County Fairgrounds in Pleasanton

CBS News

timean hour ago

  • CBS News

Invasive mosquito located at Alameda County Fairgrounds in Pleasanton

Officials in the East Bay urged residents to take precautions after the invasive Aedes aegypti mosquito was recently found at the Alameda County Fairgrounds. According to the Alameda County Mosquito Abatement District, larvae was found in a trap at the fairgrounds in Pleasanton on July 30. Several Aedes aegypti mosquitoes were found in the same area in October of last year. Before last year's discoveries, the mosquito was not seen in the county since 2014. Dr. Eric Haas-Stapleton, the district's laboratory director, said Monday, "We responded the next day by increasing our mosquito monitoring, inspection, and treatment efforts at the Alameda County Fairgrounds and surrounding neighborhoods." Also known as the yellow fever mosquito, officials said Aedes aegypti can spread multiple diseases, including dengue and Zika. The mosquito is described as aggressive and bites throughout the day. Officials urged residents in Pleasanton and throughout the county to inspect their properties for standing water. The mosquitoes are container breeders, laying eggs in small water sources such as buckets, pet dishes, fountains, bird baths and old tires. Aedes aegypti eggs are extremely small and are often mistaken for dirt or seeds. The mosquito can grow from an egg into an adult in as little as a bottle cap of water, officials said. Adult Aedes aegypti mosquitoes are described as less than a quarter inch long, with black and white stripes on its back and legs. The district said the non-native mosquito has been found in at least 26 of California's 58 counties, including neighboring counties. Residents are urged to protect themselves by using insect repellent, wearing long-sleeve shirts, pants, socks and shoes when mosquitoes are most active and to ensure window and door screens are in good condition. Anyone who sees the mosquitoes are urged to contact the district through their website or by calling 510-783-7744.

RFK Jr. pulls funding for mRNA vaccines as scientists pursue breakthrough treatments for HIV, cancer, the flu and more
RFK Jr. pulls funding for mRNA vaccines as scientists pursue breakthrough treatments for HIV, cancer, the flu and more

Yahoo

time2 hours ago

  • Yahoo

RFK Jr. pulls funding for mRNA vaccines as scientists pursue breakthrough treatments for HIV, cancer, the flu and more

Health Secretary Robert F. Kennedy Jr. announced Tuesday that the federal government is canceling nearly $500 million in funding for the development of mRNA vaccines, a revolutionary new technology that was first put into widespread use during the COVID-19 pandemic. In a video explaining the decision posted to social media, Kennedy said that the Department of Health and Human Services has determined that 'mRNA technology poses more risk than benefits' for respiratory viruses like COVID-19. He also claimed that the pandemic showed 'mRNA vaccines don't perform well against viruses that affect the upper respiratory tract.' That statement runs counter to a wide body of research finding that COVID vaccines saved millions — if not tens of millions — of lives over the course of the pandemic. A total of 22 projects funded by a government agency called the Biomedical Advanced Research and Development Authority (BARDA) will be affected by the funding freeze, according to the department. A few projects that are in their final stages will be allowed to continue, but 'no new mRNA-based projects will be initiated.' 'This isn't just about vaccines. It's about whether we'll be ready when the next crisis hits. Cutting mRNA development now puts every American at greater risk,' Rick Bright, who directed BARDA in the early stages of the pandemic before being reassigned by the Trump administration, told NBC News. The decision doesn't mean that research into mRNA vaccines will stop entirely, but it does cut off a major source of funding that helped the vaccines become a reality in the first place. By the time the pandemic had started, the government had already given an estimated $337 million in grants for research into mRNA vaccines. That support over the course of decades put scientists in a position to make COVID vaccines available to the public at a record-shattering pace of less than a year. How do mRNA vaccines work? The 'm' in mRNA stands for messenger. In the most basic terms, it's a piece of genetic code that tells our cells what to do. Scientists have discovered how to harness this process to make vaccine development much faster and less expensive. Traditional vaccines typically use a dead or weakened version of a virus to stimulate an immune response that effectively teaches the body how to combat the real version if it ever encounters it. These types of vaccines can take a long time to develop because they rely on the slow, often complicated process of cultivating and modifying the actual virus into a safe and effective form. Using mRNA is much faster because the crucial ingredients can be created and customized in a lab. It took Moderna just two days to produce its mRNA vaccine for COVID in January 2020, before most people had ever even heard of the virus. The vaccines carry a snippet of mRNA that instructs the body to produce a small portion of a virus, usually a protein on its outer membrane, which is enough to trigger the same type of immune response that is prompted by traditional vaccines. The quicker process also means that existing mRNA vaccines can be modified more rapidly when viruses evolve. Despite Kennedy's claims, mRNA-based COVID vaccines have been found to be just as effective at preventing severe infections and death as vaccines made using other methods. After the vaccines became widely available, unvaccinated people were 11 times more likely to die of COVID than those who were fully vaccinated, according to data from the Centers for Disease Control and Prevention. Two researchers who helped achieve early breakthroughs in mRNA vaccines were awarded the Nobel Prize in 2023. Applications beyond COVID The introduction of COVID vaccines didn't just mark a turning point in the deadliest pandemic in modern history. It also provided evidence of mRNA's potential to protect people from a whole range of diseases. Just last week, researchers released promising results from early trials of new mRNA-based vaccines for HIV, a huge breakthrough in a pursuit that has confounded scientists for more than 40 years. There have been tremendous strides made in drugs that protect people from catching the virus or keep them healthy if they do contract it, but the limitations of those treatments still mean that more than 600,000 people are dying every year of AIDS — mostly in the developing world. Experts see a potential vaccine as a key to finally conquering the virus. There is also optimism that mRNA could be an effective tool in combating the seasonal flu. Current flu vaccines vary widely in effectiveness from year to year, and are only about 60% effective at their best, because it can be hard for experts to predict which strain of the virus will be more dominant in any given flu season. Several pharmaceutical companies are developing mRNA flu vaccines that could become a powerful tool for fighting influenza because of how quickly they can be adapted to match the nature of the virus at any given time. That speed could be especially important if a novel flu strain, like bird flu, causes a severe outbreak. There is even some promise that mRNA might one day be used to make a universal flu vaccine that covers all strains. The holy grail for mRNA is cancer. Though vaccines are typically used to prevent disease, there are several vaccines in development that show 'real hope' of being an effective treatment for people with cancer. Those include 'individualized' vaccines that are custom-made for each patient's specific needs. An mRNA vaccine for RSV is already available to certain high-risk adults. Other possible applications include the Zika virus and cytomegalovirus, an infection that is particularly dangerous for babies and people with compromised immune systems. Though experts say the rollback of U.S. government funding is a setback for these projects, some also expressed optimism that mRNA breakthroughs will continue to come even without America's support. 'Will this dent what's going on in the U.S.? Unquestionably,' Kate Bingham, who led the United Kingdom's COVID vaccine task force, told the Guardian. 'Does that mean it's negative for the world? Not necessarily.' Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store